Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
7.03
-0.35 (-4.74%)
Nov 13, 2026, 4:00 PM EST - Market closed
Rockwell Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -5.31 | -0.48 | -8.44 | -18.68 | -32.67 |
Depreciation & Amortization | 2.19 | 2.18 | 1.44 | 0.58 | 2.52 |
Other Amortization | 0.35 | 0.43 | 1.11 | 0.37 | 0.37 |
Loss (Gain) From Sale of Assets | 0.06 | - | 0 | -0 | 0.01 |
Loss (Gain) From Sale of Investments | -0.27 | -0.07 | -0.32 | -0 | - |
Stock-Based Compensation | 1.82 | 1.29 | 0.93 | 0.32 | 0.94 |
Other Operating Activities | 2.12 | 2.39 | 3.11 | 2.62 | 0.15 |
Change in Accounts Receivable | -0.1 | 2.61 | -4.64 | -0.35 | -1.74 |
Change in Inventory | 2.78 | -0.33 | 1.18 | -2.1 | -0.66 |
Change in Accounts Payable | -0.87 | -1.65 | 0.46 | 0.31 | -0.42 |
Change in Unearned Revenue | -0.48 | -0.05 | -3.81 | -3.83 | -2.03 |
Change in Other Net Operating Assets | -2.95 | -2.11 | -0.43 | 3.83 | 0 |
Operating Cash Flow | -0.66 | 4.2 | -9.41 | -16.93 | -33.53 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.54 | -1.01 | -0.28 | -0.28 | -0.52 |
Cash Acquisitions | - | - | -12.36 | - | - |
Investment in Securities | -8 | -3.86 | 9.6 | -2.12 | 0.83 |
Investing Cash Flow | -8.54 | -4.87 | -3.05 | -2.4 | 0.31 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Repaid | -0.66 | -0.65 | -0.99 | -1.44 | -1.53 |
Long-Term Debt Repaid | -0.53 | -0.56 | -2.52 | -12.23 | -0.75 |
Total Debt Repaid | -1.19 | -1.2 | -3.51 | -13.68 | -2.28 |
Net Debt Issued (Repaid) | -1.19 | -1.2 | -3.51 | -13.68 | -2.28 |
Issuance of Common Stock | 7.82 | 10.18 | 14.86 | 15.02 | 0.11 |
Repurchase of Common Stock | - | - | - | - | -0.01 |
Other Financing Activities | -2.37 | -1.63 | -0.01 | -0.19 | - |
Financing Cash Flow | 4.25 | 7.35 | 11.34 | 16.15 | -2.18 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | - | -0.01 | -0 | -0 | - |
Net Cash Flow | -4.95 | 6.68 | -1.12 | -3.18 | -35.4 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1.2 | 3.19 | -9.7 | -17.21 | -34.06 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -1.73% | 3.14% | -11.60% | -23.64% | -54.99% |
Free Cash Flow Per Share | -0.33 | 1.03 | -4.16 | -12.03 | -39.94 |
Levered Free Cash Flow | -1.52 | 2.09 | -5.52 | -9.28 | -19.67 |
Unlevered Free Cash Flow | -1.17 | 2.45 | -5.19 | -8.44 | -18.57 |